$11.88
+0.23 (+1.97%)
Performance
1D
—
1W
—
1M
—
3M
-22.25%
6M
-37.47%
1Y
-37.47%
YTD
-37.47%
Open$11.75
Previous Close$11.65
Day High$11.97
Day Low$11.26
52W High$19.95
52W Low$9.88
Volume—
Avg Volume326.0K
Market Cap1.64B
P/E Ratio—
EPS$1.68
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
28.7
Oversold
Analyst Ratings
Strong Buy
12 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.84B | 1.33B | 1.25B |
| Net Income | 231.31M | 91.57M | 76.97M |
| Profit Margin | 12.6% | 6.9% | 6.2% |
| EBITDA | -1,152,764,794 | 140.27M | 127.47M |
| Free Cash Flow | — | 141.26M | 81.25M |
| Rev Growth | — | -6.7% | -0.7% |
| Debt/Equity | 12.59 | 0.18 | 0.17 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $9.50 | +1.82% | — | 5.54B |
| DMII | Drugs Made In America Acquis | $10.01 | -0.05% | 152.4 | 637.96M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.87B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.55 | +0.09% | 62.0 | 605.71M |
| CEPF | Cantor Equity Partners-Cl A | $10.28 | +0.24% | 96.1 | 589.22M |
| BCSS | Bain Capital Gss Inv- A | $10.15 | +0.20% | — | 593.34M |